{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:50:11Z","timestamp":1785408611105,"version":"3.56.0"},"reference-count":74,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res Clin Pract"],"DOI":"10.36416\/1806-3756\/e20260325","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:46:51Z","timestamp":1783021611000},"page":"e20260325","source":"Crossref","is-referenced-by-count":0,"title":["Brazilian guidelines for the pharmacological treatment of pulmonary hypertension and the importance of Latin American guidance in pulmonary arterial hypertension"],"prefix":"10.36416","author":[{"given":"Tomas","family":"Pulido","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03bmwyk24","id-type":"ROR","asserted-by":"publisher"}],"name":"Tecnol\u00f3gico Nacional de M\u00e9xico de Ciudad Jim\u00e9nez"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Bortman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0081fs513","id-type":"ROR","asserted-by":"publisher"}],"name":"Universidad de Buenos Aires"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"ref0","unstructured":"1. Amado VM, Pereira MC, Correa RA, Campos FAFT, Fernandes C,"},{"key":"ref1","unstructured":"Ferreira EVM, et al. Brazilian guidelines for the pharmacological"},{"key":"ref2","unstructured":"treatment of pulmonary hypertension. Official document of the"},{"key":"ref3","unstructured":"Brazilian Thoracic Society based on the Grading of Recommendations"},{"key":"ref4","unstructured":"Assessment, Development, and Evaluation methodology. Respir"},{"key":"ref5","unstructured":"Res Clin Pract. 2026;52(3):e20250528."},{"key":"ref6","unstructured":"2. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida"},{"key":"ref7","unstructured":"M, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of"},{"key":"ref8","unstructured":"pulmonary hypertension. Eur Respir J. 2023;61(1):2200879. https:\/\/"},{"key":"ref9","unstructured":"doi.org\/10.1183\/13993003.00879-2022"},{"key":"ref10","unstructured":"3. Humbert M, Gali\u00e8 N, Rubin LJ, Simonneau G, McLaughlin VV."},{"key":"ref11","unstructured":"The Seventh World Symposium on Pulmonary Hypertension: our"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"journey to Barcelona. Eur Respir J. 2024;64(4):2401222. https:\/\/doi.","DOI":"10.1183\/13993003.01222-2024"},{"key":"ref13","unstructured":"org\/10.1183\/13993003.01222-2024"},{"key":"ref14","unstructured":"4. Orozco-Levi M, Caneva J, Fernandes C, Restrepo-Jaramillo R, Zayas"},{"key":"ref15","unstructured":"N, Conde R, et al. Differences in health policies for drug availability"},{"key":"ref16","unstructured":"in pulmonary arterial hypertension and chronic thromboembolic"},{"key":"ref17","unstructured":"pulmonary hypertension across Latin America. Pulm Circ."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"2022;12:e12012. https:\/\/doi.org\/10.1002\/pul2.12012","DOI":"10.1002\/pul2.12012"},{"key":"ref19","unstructured":"5. Gali\u00e8 N, Barber\u00e0 JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin"},{"key":"ref20","unstructured":"VV, et al. Initial Use of Ambrisentan plus Tadalafil in Pulmonary"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Arterial Hypertension. N Engl J Med. 2015;373(9):834-844. https:\/\/","DOI":"10.1056\/NEJMoa1413687"},{"key":"ref22","unstructured":"doi.org\/10.1056\/NEJMoa1413687"},{"key":"ref23","unstructured":"6. Gr\u00fcnig E, Jansa P, Fan F, Hauser JA, Pannaux M, Morganti A, et al."},{"key":"ref24","unstructured":"Randomized Trial of Macitentan\/Tadalafil Single-Tablet Combination"},{"key":"ref25","unstructured":"Therapy for Pulmonary Arterial Hypertension. J Am Coll Cardiol."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"2024;83(4):473-484. https:\/\/doi.org\/10.1016\/j.jacc.2023.10.045","DOI":"10.1016\/j.jacc.2023.10.045"},{"key":"ref27","unstructured":"7. Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna"},{"key":"ref28","unstructured":"D, et al. Definition, classification, and diagnosis of pulmonary"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"hypertension. Eur Respir J. 2024;64(4):2401324. https:\/\/doi.","DOI":"10.1183\/13993003.01324-2024"},{"key":"ref30","unstructured":"org\/10.1183\/13993003.01324-2024"},{"key":"ref31","unstructured":"8. Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Gali\u00e8 N, et al."},{"key":"ref32","unstructured":"Selexipag for the treatment of pulmonary arterial hypertension."},{"key":"ref33","unstructured":"N Engl J Med. 2015;373(26):2522-33 https:\/\/doi.org\/10.1056\/"},{"key":"ref34","unstructured":"NEJMoa1503184"},{"key":"ref35","unstructured":"9. Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs"},{"key":"ref36","unstructured":"JSR, et al. Switching to riociguat versus maintenance therapy with"},{"key":"ref37","unstructured":"phosphodiesterase-5 inhibitors in patients with pulmonary arterial"},{"key":"ref38","unstructured":"hypertension (REPLACE): a multicentre, open-label, randomised"},{"key":"ref39","unstructured":"controlled trial. Lancet Respir Med. 2021;9(6):573-584. https:\/\/doi."},{"key":"ref40","unstructured":"org\/10.1016\/S2213-2600(20)30532-4"},{"key":"ref41","unstructured":"10. Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, GombergMaitland M, McLaughlin VV, et al. Phase 3 trial of sotatercept"},{"key":"ref42","unstructured":"for treatment of pulmonary arterial hypertension. N Engl J Med."},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"2023;388(16):1478-90. https:\/\/doi.org\/10.1056\/NEJMoa2213558","DOI":"10.1056\/NEJMoa2213558"},{"key":"ref44","unstructured":"11. Humbert M, McLaughlin VV, Badesch DB, Ghofrani HA, Gibbs"},{"key":"ref45","unstructured":"JSR, Gomberg-Maitland M, et al. Sotatercept in patients with"},{"key":"ref46","unstructured":"pulmonary arterial hypertension at high risk for death. N Engl J Med."},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"2025;392(20):1987-2000. https:\/\/doi.org\/10.1056\/NEJMoa2415160","DOI":"10.1056\/NEJMoa2415160"},{"key":"ref48","unstructured":"12. Hoeper MM, Pausch C, Olsson KM, Huscher D, Pittrow D, Ekkerhard"},{"key":"ref49","unstructured":"G, et al. COMPERA 2.0: A refined 4-strata risk assessment model for"},{"key":"ref50","unstructured":"pulmonary arterial hypertension. Eur Respir J. 2022;60(1):2102311."},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1183\/13993003.02311-2021","DOI":"10.1183\/13993003.02311-2021"},{"key":"ref52","unstructured":"13. Maron B, Bortman G, De Marco T, Huston JH, Lang IM,"},{"key":"ref53","unstructured":"Rosenkranz SH, et al. Pulmonary hypertension associated with"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"left heart disease. Eur Respir J. 2024;64(4):2401344. https:\/\/doi.","DOI":"10.1183\/13993003.01344-2024"},{"key":"ref55","unstructured":"org\/10.1183\/13993003.01344-2024"},{"key":"ref56","unstructured":"14. Nathan SD, Behr J, Collard HR, Cottin V, Hoeper MM, Martinez"},{"key":"ref57","unstructured":"FJ, et al. Riociguat for idiopathic interstitial pneumonia-associated"},{"key":"ref58","unstructured":"pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"phase 2b study. Lancet Respir Med. 2019;7(9):780-90 https:\/\/doi.","DOI":"10.1016\/S2213-2600(18)30475-2"},{"key":"ref60","unstructured":"org\/10.1016\/S2213-2600(19)30250-4"},{"key":"ref61","unstructured":"15. Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A,"},{"key":"ref62","unstructured":"Engel P, Bajwa A, et al. Inhaled treprostinil in pulmonary hypertension"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"due to interstitial lung disease. N Engl J Med. 2021;384(4):325-34.","DOI":"10.1056\/NEJMoa2008470"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa2008470","DOI":"10.1056\/NEJMoa2008470"},{"key":"ref65","unstructured":"16. Nathan SD, Argula R, Trivieri MG, Aziz S, Gay E, Medarov B, et"},{"key":"ref66","unstructured":"al. Inhaled treprostinil in pulmonary hypertension associated with"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"COPD: PERFECT study results. Eur Respir J. 2024;63(6):2400172.","DOI":"10.1183\/13993003.00172-2024"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1183\/13993003.00172-2024","DOI":"10.1183\/13993003.00172-2024"},{"key":"ref69","unstructured":"17. Kuo WT, Banerjee A, Kim PS, DeMarco FJ Jr, Levy JR, Facchini"},{"key":"ref70","unstructured":"FR, et al. Pulmonary Embolism Response to Fragmentation,"},{"key":"ref71","unstructured":"Embolectomy, and Catheter Thrombolysis (PERFECT): Initial Results"},{"key":"ref72","unstructured":"From a Prospective Multicenter Registry. Chest. 2015;148(3):667-"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"673. https:\/\/doi.org\/10.1378\/chest.15-0119","DOI":"10.1378\/chest.15-0119"}],"container-title":["Respiratory Research &amp; Clinical Practice"],"original-title":[],"link":[{"URL":"https:\/\/www.ithenticate.com\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:47:50Z","timestamp":1783021670000},"score":1,"resource":{"primary":{"URL":"https:\/\/rrcpjournal.org\/article\/brazilian-guidelines-for-the-pharmacological-treatment-of-pulmonary-hypertension-and-the-importance-of-latin-american-guidance-in-pulmonary-arterial-hypertension\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":74,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20260325","relation":{},"ISSN":["3086-3910"],"issn-type":[{"value":"3086-3910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"2026-0325"}}